Cooper Companies | COO - Umsatzkosten

Aktienkurs
71.21
Täglich Wechseln
-0.25 -0.35%
Monatlich
-3.44%
Jährlich
-8.07%
Q2 Prognose
68.06




Umsatzkosten Veränderung Datum
Abbott USD 4.92B 535M 2025-12
Align Technology USD 363.97M 7.48M 2025-12
AtriCure USD 35.16M 2.23M 2025-12
Avanos Medical USD 94.9M 3.1M 2025-12
Bausch Health Companies USD 1.03B 284M 2025-12
Baxter International USD 2.4B 512M 2025-12
Bayer EUR 4.5B 194M 2025-12
Becton, Dickinson and Co. USD 2.84B 2.35B 2025-12
Boston Scientific USD 1.84B 82M 2025-12
Cooper Companies USD 376.8M 87.4M 2025-12
Dentsply International USD 518M 55M 2025-12
Dexcom USD 466.9M 11M 2025-12
Edwards Lifesciences USD 343M 2.2M 2025-12
Globus Medical USD 290.47M 8.09M 2025-12
Haemonetics USD 136.58M 4.01M 2025-12
Hologic USD 463.7M 5.1M 2025-12
Inogen USD 39.59M 1.27M 2024-09
Insulet USD 215.2M 19M 2025-12
Integra LifeSciences USD 193.44M 1.62M 2025-12
Intuitive Surgical USD 961.9M 119.2M 2025-12
J&J USD 7.97B 689M 2025-12
Medtronic USD 3.61B 83M 2025-12
Merit Medical Systems USD 198.58M 838K 2025-12
Novartis USD 3.54B 7M 2025-12
ResMed USD 555.85M 29.13M 2025-12
STAAR Surgical USD 14.06M 2.8M 2025-12
Steris USD 840.7M 26.3M 2025-12
Stryker USD 2.69B 373M 2025-12
Tandem Diabetes Care USD 122.92M 7.96M 2025-12
Teleflex USD 261.54M 199.84M 2025-12
Utah Medical Products USD 3.78M 419K 2025-12
Zimmer Biomet Holdings USD 970.1M 234.3M 2025-12